Your browser doesn't support javascript.
loading
The Impact of Chronic Endometritis on Infertility: Prevalence, Reproductive Outcomes, and the Role of Hysteroscopy as a Screening Tool.
Geysenbergh, Brecht; Boes, Anne-Sophie; Bafort, Céline; Van Rompuy, Anne-Sophie; Neyens, Sara; Lie-Fong, Sharon; Debrock, Sophie; Vriens, Joris; De Loecker, Peter; Dancet, Eline; D'Hooghe, Thomas; Peeraer, Karen.
Affiliation
  • Geysenbergh B; Department of Gynaecology, UZ Leuven, Leuven, Belgium.
  • Boes AS; Department of Gynaecology, GZA Hospitals, Antwerp, Belgium.
  • Bafort C; Department of Gynaecology, UZ Leuven, Leuven, Belgium.
  • Van Rompuy AS; Department of Gynaecology, AZ Diest, Diest, Belgium.
  • Neyens S; Department of Gynaecology, UZ Leuven, Leuven, Belgium.
  • Lie-Fong S; Department of Pathology, UZ Leuven, Leuven, Belgium.
  • Debrock S; Department of Gynaecology, Jessa Hospital, Hasselt, Belgium.
  • Vriens J; Department of Gynaecology, UZ Leuven, Leuven, Belgium.
  • De Loecker P; Department of Development and Regeneration, KULeuven, Leuven, Belgium.
  • Dancet E; Department of Gynaecology, UZ Leuven, Leuven, Belgium.
  • D'Hooghe T; Department of Development and Regeneration, KULeuven, Leuven, Belgium.
  • Peeraer K; Lab of Endometrium, Endometriosis and Reproductive Medicine, Department of Development and Regeneration, KULeuven, Leuven, Belgium.
Gynecol Obstet Invest ; 88(2): 108-115, 2023.
Article in En | MEDLINE | ID: mdl-36739858
ABSTRACT

OBJECTIVES:

The objective of this study was to examine the prevalence of chronic endometritis (CE) in infertile women, its impact on reproductive outcomes, and the accuracy of hysteroscopy as a screening tool for CE.

DESIGN:

This was a prospective observational study.

PARTICIPANTS:

Participants involved in this study were 514 asymptomatic patients with infertility.

SETTING:

The review was conducted in a tertiary care center.

METHODS:

The participants underwent a hysteroscopy and endometrial biopsy (EMB). Antibiotics were given for cases of CE. We investigated the prevalence of CE in patients starting assisted reproductive technologies (ART) as a primary outcome. Secondary outcomes were the clinical pregnancy rate (CPR) in the ART cycle after hysteroscopy, EMB, and antibiotic treatment in cases of CE; the cumulative CPR in the subsequent 2 years after hysteroscopy and EMB; the sensitivity and specificity of hysteroscopy as a screening tool compared to EMB as the "gold standard" for diagnosing CE.

RESULTS:

CE was identified in 2.8% of patients starting ART (11/393). CPRs did not differ significantly between patients with CE and the entire cohort of patients without CE in the subsequent ART cycle (OR 0.43; 95% CI 0.09-2.02) or in the 2 years after EMB (OR 0.56; 95% CI 0.16-1.97). In a matched control comparison (with matching for age, basal FSH, and cause of infertility), CPR in patients with CE did not differ in the subsequent ART cycle (OR 0.39; 95% CI 0.09-1.61); however, their CPR in the 2 years after EMB was significantly lower (OR 0.22; 95% CI 0.13-0.38). The sensitivity and specificity of hysteroscopy as a screening tool for diagnosing CE were 8.3% and 90.1%, respectively.

LIMITATIONS:

Due to our cohort's low CE prevalence, we could not detect significant differences in CPRs.

CONCLUSION:

CE is rare in our studied population of asymptomatic patients starting ART. Hysteroscopy cannot replace EMB for diagnosing CE.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hysteroscopy / Endometritis / Infertility, Female Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Pregnancy Language: En Journal: Gynecol Obstet Invest Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hysteroscopy / Endometritis / Infertility, Female Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Pregnancy Language: En Journal: Gynecol Obstet Invest Year: 2023 Document type: Article